Compliance of Clinical Trial Protocols for Foods with Function Claims (FFC) in Japan: Consistency between Clinical Trial Registrations and Published Reports.

clinical trial registration compliance foods protocol randomized controlled trial

Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
25 Dec 2021
Historique:
received: 25 11 2021
revised: 21 12 2021
accepted: 23 12 2021
entrez: 11 1 2022
pubmed: 12 1 2022
medline: 27 1 2022
Statut: epublish

Résumé

A new type of foods with a health claims notification system, the Foods with Function Claims (FFC), was introduced in Japan in April 2015. This cross-sectional study sought to clarify compliance of clinical trial protocols reported as the scientific basis of efficacy in the FFC system. All articles based on clinical trials published on the Consumer Affairs Agency website from 1 July 2018 to 30 June 2021 were reviewed. Items assessed included first author characteristics (for-profit or academia), journal name, year published, journal impact factor in 2020, article language, name of clinical trial registration (CTR), and seven compliance items (Title: T, Participant: P, Intervention: I, Comparison: C, Outcome: O, Study design: S, and Institutional Review Board, IRB). Among studies that conducted CTR, consistency with these seven compliance items was evaluated. Out of 136 studies that met all inclusion criteria, 103 (76%) performed CTR, and CTR was either not performed or not specified for 33 (24%). Compliance between the protocol and the text was high (≥96%) for items P and S, but considerably lower for items T, I, C, O, and IRB (52%, 15%, 13%, 69%, and 27%, respectively). Furthermore, 43% of protocols did not include functional ingredients or food names in items T or I. The total score was 3.7 ± 1.1 pts (out of 7). Some CTs had no protocol registration, and even registered protocols were suboptimal in transparency. In addition to selective reporting, a new problem identified was that the content of the intervention (test food) was intentionally concealed.

Sections du résumé

BACKGROUND BACKGROUND
A new type of foods with a health claims notification system, the Foods with Function Claims (FFC), was introduced in Japan in April 2015. This cross-sectional study sought to clarify compliance of clinical trial protocols reported as the scientific basis of efficacy in the FFC system.
METHODS METHODS
All articles based on clinical trials published on the Consumer Affairs Agency website from 1 July 2018 to 30 June 2021 were reviewed. Items assessed included first author characteristics (for-profit or academia), journal name, year published, journal impact factor in 2020, article language, name of clinical trial registration (CTR), and seven compliance items (Title: T, Participant: P, Intervention: I, Comparison: C, Outcome: O, Study design: S, and Institutional Review Board, IRB). Among studies that conducted CTR, consistency with these seven compliance items was evaluated.
RESULTS RESULTS
Out of 136 studies that met all inclusion criteria, 103 (76%) performed CTR, and CTR was either not performed or not specified for 33 (24%). Compliance between the protocol and the text was high (≥96%) for items P and S, but considerably lower for items T, I, C, O, and IRB (52%, 15%, 13%, 69%, and 27%, respectively). Furthermore, 43% of protocols did not include functional ingredients or food names in items T or I. The total score was 3.7 ± 1.1 pts (out of 7).
CONCLUSIONS CONCLUSIONS
Some CTs had no protocol registration, and even registered protocols were suboptimal in transparency. In addition to selective reporting, a new problem identified was that the content of the intervention (test food) was intentionally concealed.

Identifiants

pubmed: 35010956
pii: nu14010081
doi: 10.3390/nu14010081
pmc: PMC8746435
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

JAMA Intern Med. 2019 Nov 1;179(11):1593-1594
pubmed: 31355871
Nutr Res. 2017 Apr;40:21-31
pubmed: 28473057
JAMA. 2009 Sep 2;302(9):977-84
pubmed: 19724045
PLoS Med. 2010 Mar 24;7(3):e1000251
pubmed: 20352064
J Clin Epidemiol. 2015 Sep;68(9):1059-67
pubmed: 25542517
Trials. 2018 Aug 23;19(1):448
pubmed: 30134950
Cochrane Database Syst Rev. 2011 Jan 19;(1):MR000031
pubmed: 21249714
Nutrients. 2019 Jul 12;11(7):
pubmed: 31336978
N Engl J Med. 2008 Jan 17;358(3):252-60
pubmed: 18199864
BMC Med Res Methodol. 2020 Sep 7;20(1):224
pubmed: 32894068
BMJ. 2013 Sep 06;347:f5248
pubmed: 24014339
Cochrane Database Syst Rev. 2009 Jan 21;(1):MR000006
pubmed: 19160345
J Am Osteopath Assoc. 2020 Dec 1;120(12):823-830
pubmed: 33075122
Ther Innov Regul Sci. 2019 Sep;53(5):623-629
pubmed: 30380916
BMJ. 2020 Apr 14;369:m982
pubmed: 32291261
BMJ Open. 2020 Feb 17;10(2):e035283
pubmed: 32071191
Perspect Clin Res. 2016 Jul-Sep;7(3):132-6
pubmed: 27453830
BMJ. 2003 May 31;326(7400):1171-3
pubmed: 12775615
Trials. 2020 Jun 8;21(1):494
pubmed: 32513240
BMJ. 2010 Mar 23;340:c869
pubmed: 20332511
BMJ. 2016 Feb 17;352:i637
pubmed: 26888209
BMC Med Res Methodol. 2021 Jun 8;21(1):120
pubmed: 34103009
Ann Intern Med. 2013 Feb 5;158(3):200-7
pubmed: 23295957
Trials. 2011 Sep 28;12:214
pubmed: 21955551
Lancet. 2014 Jan 11;383(9912):101-4
pubmed: 24411643
BMJ. 2010 Feb 15;340:c365
pubmed: 20156912
World J Surg. 2021 Apr;45(4):1031-1042
pubmed: 33462704
J Clin Epidemiol. 2016 Jul;75:100-7
pubmed: 26820559
PLoS One. 2013 Apr 10;8(4):e59910
pubmed: 23593154
BMJ. 2019 Jul 31;366:l4378
pubmed: 31366597
JAMA. 2004 May 26;291(20):2457-65
pubmed: 15161896

Auteurs

Hiroharu Kamioka (H)

Faculty of Regional Environment Science, Tokyo University of Agriculture, 1-1-1 Sakuragaoka, Setagaya-ku, Tokyo 156-8502, Japan.

Hideki Origasa (H)

Division of Biostatistics and Clinical Epidemiology, School of Medicine, University of Toyama, 2630 Sugiya, Toyama 930-0194, Japan.

Jun Kitayuguchi (J)

Physical Education and Medicine Research Center Unnan, 328 Uji, Unnan City 699-1105, Japan.

Kiichiro Tsutani (K)

Facult of Health Sciences, Tokyo Ariake Medical and Health Sciences University, 2-9-1 Ariake, Kouto-ku, Tokyo 135-0063, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH